摘要
【摘 要】目的：慢急性白血病应用血液分析仪的检验价值分析。方法：选取 2016年 7月 -2019年 7月本院诊治慢急性白血病 80例患者临床资料，按照疾病类型分为两组，急性组 55例，慢性组 25例，同期选取健康者 30例资料，设为对照组，分析三组血液相关指标情况。结果：急性组 C反应蛋白（ 197.23±9.25） mg/L、白细胞（ 83.28±8.28） *109/L及慢性组（ 119.31±8.62） mg/L、（ 48.14±7.25） *109/L，均比对照组高（ P<0.05） ;且急性组血红蛋白（ 33.16±5.71） g/L、慢性组（ 49.24±8.15） g/L均比对照组低（ P<0.05），急性组及慢性组血液相关指标比较，差异具统计意义（ P<0.05）。结论：慢急性白血病应用血液分析仪的临床检验，可用于白血病诊断及急慢性类型的鉴别，为临床治疗方案的制定提供参考依据，具一定临床应用价值。
【关键词】慢性 ;急性白血病 ;血液分析仪 ;检验价值
Objective: to analyze the value of Hematology Analyzer in the diagnosis of chronic acute leukemia. Methods: the clinical data of 80 patients with chronic acute leukemia in our hospital from July 2016 to July 2019 were selected and divided into two groups according to the disease types, 55 cases in the acute group and 25 cases in the chronic group. At the same time, 30 cases of healthy people were selected as the control group, and the blood related indicators of the three groups were analyzed. Results: C-reactive protein (CRP) (197.23 ± 9.25) mg / L, WBC (83.28 ± 8.28) * 109 / L in acute group and (119.31 ± 8.62) mg / L and (48.14 ± 7.25) * 109 / L in chronic group were higher than those in control group (P < 0.05); The levels of hemoglobin in acute group (33.16 ± 5.71) g / L and chronic group (49.24 ± 8.15) g / L were lower than those in control group (P < 0.05). The difference of blood related indexes between acute group and chronic group was statistically significant (P < 0.05). Conclusion: the clinical test of hematology analyzer can be used for the diagnosis of leukemia and the identification of acute and chronic types, which can provide reference for the formulation of clinical treatment plan, and has certain clinical application value.
出版日期
2020年09月14日（中国期刊网平台首次上网日期，不代表论文的发表时间）
